Mobilization of cryptic antibiotic biosynthesis loci from human-pathogenic Nocardia.

ABSTRACT

The cloning and heterologous expression of natural product biosynthetic gene clusters has helped to identify many new bioactive molecules and conclusively connect genes to compounds. Much of this work has been performed on gene clusters from the natural product powerhouse genus, Streptomyces. However, other actinomycetes, such as Nocardia, have clear potential to produce bioactive molecules, but a lack of genetic systems for manipulation of their genomes has hampered progress. As such, systems for the cloning of large DNA fragments, such as transformation associated recombination (TAR), provide opportunities to move genes of interest from a native host into a more genetically tractable heterologous organism, thereby allowing natural product biosynthesis to be further explored. Here, we present a protocol to identify, clone and heterologously express biosynthetic gene clusters from the genus Nocardia to assist in the identification of novel bioactive natural products.